Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
about
A randomised controlled trial of triple antiplatelet therapy (aspirin, clopidogrel and dipyridamole) in the secondary prevention of stroke: safety, tolerability and feasibilityThe effect of preoperative treatment of P2Y12 receptor antagonists on perioperative bleeding and mortality in patients treated with coronary artery bypass grafting (CABG)The effect of preoperative treatment of P2Y12 receptor antagonists on perioperative bleeding and mortality in patients treated with coronary artery bypass grafting (CABG)Multiple versus one or more antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attackAdenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitusClopidogrel plus aspirin versus aspirin alone for preventing cardiovascular diseaseClopidogrel plus aspirin versus aspirin alone for preventing cardiovascular diseaseOral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacksAspirin and extended-release dipyridamole versus clopidogrel for recurrent strokeEpidemiology, classification, and modifiable risk factors of peripheral arterial diseasePlatelet function and ageingCurrent status of high on-treatment platelet reactivity in patients with coronary or peripheral arterial disease: Mechanisms, evaluation and clinical implicationsShould dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trialsComing safely to a stop: a review of platelet activity after cessation of antiplatelet drugsTIA Management: Should TIA Patients be Admitted? Should TIA Patients Get Combination Antiplatelet Therapy?Clopidogrel and Aspirin versus Aspirin Alone for Stroke Prevention: A Meta-AnalysisCurrent perspectives in NSAID-induced gastropathyTreatment and prevention of gastrointestinal bleeding in patients receiving antiplatelet therapyEffect of addition of clopidogrel to aspirin on mortality: systematic review of randomized trialsBiomarkers for strokeLimb salvage in womenLost in translation: what have we learned from the CHARISMA trial?Clopidogrel in ST-elevation myocardial infarction patients undergoing percutaneous coronary interventionUse of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control studyAspirin and clopidogrel resistance: consideration and managementAntithrombotic treatment for peripheral arterial diseaseThe safety and efficacy of aspirin and clopidogrel as a combination treatment in patients with coronary heart diseaseMy health: whose responsibility? Low-dose aspirin and older peoplePrasugrelEvolving perspectives on clopidogrel in the treatment of ischemic strokeClinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic diseasePharmacological interventions for peripheral artery diseaseClopidogrel: an updated and comprehensive reviewRisk reduction with clopidogrel in the management of peripheral arterial diseaseRationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patientAnithrombotic prevention in vascular disease: bases for a new strategy in antithrombotic therapyPharmacological prevention of atherothrombotic events in patients with peripheral arterial diseaseContemporary issues in clopidogrel therapy: new evidence shaping clinical practiceHypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapyThe PRoFESS trial: future impact on secondary stroke prevention
P2860
Q21144269-148E130F-7C0B-4876-96CA-08AB23C45036Q24187718-070215B2-5DCB-4695-83DB-3891746B07D1Q24197708-7D581857-643A-4EC0-9B0C-BDCD362C6A3EQ24201386-5BDCA05C-E4EE-47AB-AE5E-9605911E478FQ24203035-EE26F34A-2F25-4C55-9FA1-9A8382976ED0Q24234632-9775C03B-3409-4ACB-8884-E6DD20D1EB2FQ24243939-AA8B253D-ADEC-46C0-A117-1002AFAF2B69Q24244298-D1930FE4-7882-47F2-BDF2-EE508230D114Q24646522-BBE489B6-1735-48E5-9D1F-6F71DB3C2FA5Q24681271-6DE64834-FCEE-4E25-95AF-86B4018C2457Q26749231-84DB9C35-8663-469A-90CA-F8DDDECE5EC9Q26771106-EEA7D97B-8278-485F-A1B2-9FC1EC9B97A7Q26782970-E1B59DA1-FAA1-4F43-8509-6909A9AB7F13Q26795403-D2298367-B910-4D85-9328-D2643E4438E0Q26796466-0EA01426-7330-4ADA-878E-E932C7F0CEF7Q26798213-39BB9FFB-2613-4A24-9948-336CC20426A0Q26827673-C99C61D1-B6E0-4F4C-AA37-2E9CEDC41C25Q26866350-1C5203C3-AF0C-436E-BB11-B714F3A38AEDQ26999848-D3003278-56F5-4899-92F3-A96D0B721EE8Q27004404-B71CFA4A-B32F-4579-B7B4-5FA019FBC501Q27010121-74766E36-11DA-4127-99F4-55323924A4DBQ28199586-24829CE4-E7DA-4AEC-90EF-12E75D1203FEQ28199817-388D0642-1988-48BC-80CF-18E37323E29FQ28200506-949CF965-7F0D-4F42-950E-9C29790DE559Q28200610-CE5E4088-627B-49F0-A60C-B073FA38020FQ28200650-74A3D48B-D73D-4A53-BD08-CAD200F5AA92Q28200757-05936EA7-C131-4252-B558-FD112AA34622Q28201631-DF439EA2-79A2-4050-8B9B-F17A7AD3E235Q28210429-CC04008D-2F4D-4CFC-86A1-5A0C946FB074Q28217627-50013450-D00B-41F8-B15D-0C1F2F50CECAQ28218124-BF716097-BBC5-40DC-A3A6-A954B1A781D4Q28218976-9CB48999-0BB1-4303-B353-D730E5F8A74EQ28219411-DF72E1AF-B353-44D8-8945-5031F61C13B0Q28219578-DD26B751-C976-498D-8DC5-F704EED75B5EQ28219951-58541C3D-A95F-4CC2-9B69-9E42855A3672Q28220433-D294AA7B-4A21-46B0-B8B7-E7FCC4E80A0CQ28220999-62527C5B-E513-4DA9-BBFE-89F036A4CD5EQ28221366-F9DE1795-9484-4154-B88C-5D5456BAAB49Q28221437-054BD0E8-C3A6-4826-A371-F8BAC82F5EE3Q28221589-D2664298-1A05-463F-A22F-180464EB8F12
P2860
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Clopidogrel and aspirin versus ...... ion of atherothrombotic events
@ast
Clopidogrel and aspirin versus ...... ion of atherothrombotic events
@en
Clopidogrel and aspirin versus ...... ion of atherothrombotic events
@nl
type
label
Clopidogrel and aspirin versus ...... ion of atherothrombotic events
@ast
Clopidogrel and aspirin versus ...... ion of atherothrombotic events
@en
Clopidogrel and aspirin versus ...... ion of atherothrombotic events
@nl
prefLabel
Clopidogrel and aspirin versus ...... ion of atherothrombotic events
@ast
Clopidogrel and aspirin versus ...... ion of atherothrombotic events
@en
Clopidogrel and aspirin versus ...... ion of atherothrombotic events
@nl
P2093
P50
P3181
P356
P1476
Clopidogrel and aspirin versus ...... ion of atherothrombotic events
@en
P2093
Christian W Hamm
Eric A Cohen
Henry R Black
J Donald Easton
Jean-Louis Mas
Joan Booth
Keith A A Fox
Koon-Hou Mak
Liz Fabry-Ribaudo
Marcus D Flather
P304
P3181
P356
10.1056/NEJMOA060989
P407
P50
P577
2006-04-20T00:00:00Z